Effect of propofol administration on pancreatic enzymes and lipid biochemistry in children undergoing open heart surgery

Effect of propofol administration on pancreatic enzymes and lipid biochemistry in children undergoing open heart surgery - Effect of propofol administration on pancreatic enzymes and lipid biochemistry in children undergoing open heart surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012242

Enrollment

Registered

2013-11-08

Start date

2013-11-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children under 36 months who is scheduled for surgical closure of atrial septum defect or ventricular septum defect

Interventions

1% propofol 2% propofol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with atrial septal defect or ventricular septal defect who is scheduled for surgical closure of the defect.

Exclusion criteria

Exclusion criteria: hepatic, renal, neurological or respiratory disease, fat intolerance or any congenital metabolic disorder

Design outcomes

Primary

Measure	Time frame
serum triglycerides, serum cholesterol, serum phospholipids, serum high-density lipoproteins, serum low-density lipoproteins, serum very low-density lipoproteins, serum total lipids, serum amylase, serum lipase	—

Countries

Japan

Contacts

Public ContactKeiichiro Mizuno

Fukuoka Children's Hospital Department of Anesthesia

mizuno.k@fcho.jp092-682-7000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026